systems generate. Regulatory references supporting sponsor involvement include:

• ICH GCP E6(R2): Section 5.1.1 – Sponsor retains responsibility for overall trial conduct, even when duties are delegated.
• EMA Reflection Paper on TMF: Emphasizes audit trail review as part of sponsor oversight obligations.
• FDA BIMO Program: Frequently cites sponsor failure to verify TMF audit trails as a GCP deficiency.

This means sponsors must actively engage in audit trail review workflows, approve related SOPs, and request regular reports or dashboards from CRO partners handling TMF documentation.

Types of Audit Trail Reviews Sponsors Should Perform

Sponsors are not expected to review every single audit log entry — but they must implement a risk-based approach to periodic oversight. Key activities include:

• Reviewing audit trails for protocol versions and approvals
• Validating that informed consent documents follow change control procedures
• Confirming finalization and QC of essential documents (e.g., monitoring reports)
• Cross-checking CRO QC workflows against system logs
• Ensuring deletion or document replacement actions are properly justified and logged

Consider this example:

Document	Action	Performed By	Reviewed By (Sponsor)	Review Date
ICF v2.0	Approved	CRO Doc Manager	sponsor.qc@company.com	2025-08-10
Site CV v3.1	Deleted	CRO Admin	sponsor.qc@company.com	2025-08-11

Tracking and confirming these activities supports both data integrity and regulatory compliance.

Formalizing Sponsor Oversight of Audit Trails

Sponsor involvement must be embedded in standard operating procedures (SOPs), quality agreements, and monitoring plans. This ensures clarity across internal and outsourced teams. The sponsor’s audit trail review process should include:

• Frequency of audit trail review (monthly, quarterly, per milestone)
• List of critical documents requiring direct sponsor audit trail checks
• Escalation protocols for discrepancies or unauthorized changes
• Defined user roles with read-only access to audit logs
• Documentation of sponsor review in a TMF audit log or sponsor QC tracker

This process must also align with the CRO’s document management and eTMF access model. All stakeholders should agree on who performs initial reviews, who approves final versions, and who monitors audit logs over time.

Technology Solutions That Facilitate Sponsor Audit Trail Access

Most modern eTMF platforms offer sponsor-side access to real-time audit logs. Sponsors should ensure their systems or CRO platforms allow:

• Dashboards showing audit trail trends (e.g., document deletions, delayed approvals)
• Searchable logs by document ID, action type, or user
• Export functions (CSV, PDF) for inspector presentation
• Email alerts for high-risk changes (e.g., deletion, version replacement)
• Role-based access without edit rights

For example, the sponsor can configure alerts to notify the QA lead if any document in the “Essential Documents” category is revised without an associated approval entry within 48 hours.

Sponsor-CRO Collaboration for Shared Oversight

Clear expectations must be set between sponsors and CROs regarding audit trail handling. The quality agreement should address:

• Which audit trails the CRO reviews vs which the sponsor reviews
• How sponsor feedback is documented and acted upon
• Timelines for escalation and resolution of audit trail concerns
• Joint periodic audit trail assessments (especially pre-inspection)

Regular alignment meetings — monthly or quarterly — should include review of audit trail metrics and a summary of anomalies flagged during the period. Sponsors must be empowered to ask questions and request additional log samples as needed.

Training Sponsor Personnel on Audit Trail Oversight

Sponsors should not assume all internal stakeholders understand audit trail functionality. Training is essential and should include:

• Overview of audit trail regulatory expectations (FDA, EMA, MHRA)
• Live demos of navigating the eTMF system to access logs
• How to read and interpret audit trail entries
• What anomalies to look for (e.g., rapid version changes, missing approvals)
• How to document sponsor reviews and follow-ups

Documented training logs should be retained in the TMF as part of inspection readiness materials.

Case Study: How Sponsor Oversight Prevented an Inspection Finding

In a recent Phase III inspection by the FDA, a CRO had mistakenly uploaded a site closeout report under the incorrect study ID and then replaced it without documented justification. The sponsor’s QA team, performing a routine quarterly audit trail review, caught the replacement and requested a corrective log note. This action was documented and explained proactively during the inspection, avoiding a potential GCP finding.

This example illustrates how sponsor audit trail oversight — even if periodic — provides critical assurance for data integrity.

Checklist: Sponsor Responsibilities for Audit Trail Reviews

• ✔️ Are sponsor roles for audit trail review defined in SOPs?
• ✔️ Is there read-only access to CRO audit logs?
• ✔️ Are high-risk documents reviewed by the sponsor at defined intervals?
• ✔️ Are issues identified by the sponsor tracked and resolved?
• ✔️ Are joint audit trail reviews planned pre-inspection?
• ✔️ Are sponsor reviewers trained in audit trail systems?
• ✔️ Is sponsor feedback documented in QC trackers or CAPA logs?

Conclusion

Regulatory agencies place final responsibility for trial documentation integrity squarely on the sponsor. In the age of electronic TMFs and increasing reliance on CROs, sponsor oversight of audit trails is more important than ever. Implementing structured review processes, leveraging technology, training internal teams, and fostering sponsor-CRO collaboration can collectively ensure audit trail readiness and protect against regulatory risk.

To explore transparency models and public audit histories, visit WHO’s International Clinical Trials Registry Platform.